TrialBreast cancer research and treatment2018

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

Joyce O'Shaughnessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.